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OBJECTIVES We report an in-depth postmortem morphologic analysis of atrial myocardium in human
pulmonary veins (PVs) from patients with and without atrial fibrillation (AF).
BACKGROUND Electrophysiologic studies established the critical role of PVs in the initiation of AF. To date,
a paucity of data exists about PV morphology as an arrhythmogenic substrate.
METHODS Longitudinal tissue-strips of PVs were excised and histologically analyzed from the distal part
to just beyond the atriovenous junction in the left atrium from 20 patients, obtained at
autopsy. Anatomical measurements, including diameters, lengths, and wall-thicknesses of
PVs, obtained at autopsy, were made.
RESULTS Histological analysis revealed extension of atrial myocardium into 89% of all PVs. Prevalence
of myocardial extension was significantly higher in veins of 6 patients with compared with 14
patients without AF. Other significant differences in the histology of PVs between the two
groups were a higher frequency of discontinuity and hypertrophy and a higher degree of
fibrosis of the atrial myocardium in the PVs of patients with AF. A marked variation existed
in anatomical dimensions of PVs, although no differences were observed between patients
with or without AF.
CONCLUSIONS Atrial myocardium was more often present in the PVs of patients with compared with
patients without AF. In the first group, the atrial myocardium in the PVs was characterized
by more severe discontinuity, hypertrophy, and fibrosis. A marked variation in anatomical
dimensions of the PVs existed. (J Am Coll Cardiol 2003;42:1108–14) © 2003 by the
American College of Cardiology Foundation
Animal and human histological studies of the pulmonary
veins (PVs), which date back to the 19th century, have
reported extension of atrial myocardium beyond the atrio-
venous junction (1–5). Clinical electrophysiologic studies
have demonstrated that the PVs are of pathophysiologic
importance and can play a critical role in the initiation of
atrial fibrillation (AF) in some patients (6–11). These
studies reported a prominent clustering of tachycardia foci
within the PVs, especially the superior veins.
Because of the clinical importance of the PVs in the
initiation of AF and the increasingly widespread application
of catheter ablation techniques in these veins as a treatment
for AF, we undertook this study to define more precisely the
morphologic characteristics of the PVs and their left atrial
junctions. Limited data concerning the histology of the
extended atrial myocardium in the PVs are currently avail-
able in humans. Furthermore, only a paucity of data exists
that compares the morphology of the pulmonary venous
wall from patients with AF with patients without the
arrhythmia. Therefore, we studied the postmortem histo-
logical morphology of the atrial myocardium in the PVs and
compared this between both patient groups. Secondly, we
measured various postmortem anatomical dimensions of the
PVs of patients with and without AF before death.
METHODS
Study populations. Histological studies were performed in
20 human hearts obtained at autopsy. The clinical data of
the 20 patients for the histology study are represented in
Table 1. The average age of this group (7 female, 13 male)
was 65.0 ( 19.8) years. A history of persistent AF was
found in 6 of 20 patients. The average age of the patients
with a history of AF (3 female, 3 male) was 75.2 ( 15.8)
years. The average age of the patients without a history of
AF (4 female, 10 male) was 60.6 ( 20.2) years. Anatomical
measurements were made of PVs from 17 human hearts
obtained at autopsy. The clinical characteristics are given in
Table 2. The average age of the patients (5 female, 12 male)
from which the veins were derived was 68.7 ( 12.4) years.
According to their medical records, 5 of 17 patients had
persistent AF before death. Patients who had undergone
cardiac surgery or had involvement of the pulmonary hilar
regions by malignancy were excluded from both study sets.
The histology and the anatomy study were not carried out at
the same time, but partially overlapped each other, which
explains that both study groups do not consist of exactly the
same patient population.
Histological analysis. The lungs and hearts of 20 patients
were obtained at autopsy. The junctions of the PVs with the
left atrium were marked with a thin line of Indian ink on the
external surface using a micropipette. Longitudinal strips of
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tissue, approximately 5-mm wide, were excised from the
distal end of the PV in the lung to the left atrium just
beyond the atriovenous junction. Sections of the anterior
and posterior wall of all four PVs were taken, resulting in
eight sections per patient. The tissue samples were imme-
diately fixed in 10% neutral buffered formalin for more than
24 h. After standard tissue processing, the sections were
embedded in paraffin and cut at 6 m and stained with
Masson’s trichrome and immunohistochemically with
monoclonal mouse anti-smooth muscle actin (SMA) (Sig-
ma, St. Louis, Missouri; prediluted) and monoclonal mouse
anti-cardiac troponin-T (Accurate Chemical & Scientific
Corp., Westbury, New York; dilution: 1:50) in order to
distinguish between smooth and atrial myocardial muscle,
respectively. Incubation of antibodies was preceded by
microwave pre-treatment. Before all staining procedures,
paraffin sections were deparaffinized with xylene (2  5
min) and dehydrated with 100% ethanol (2  5 min) and
95% ethanol (2  5 min). The incubation time was 60 min
for both antibodies. The secondary antibody used for the
anti-SMA was a goat anti-mouse IgG (Sigma), and for
anti-troponin-T it was a biotinylated broad spectrum IgG
(Zymed, San Francisco, California). All staining was done
by the Streptavidin-biotin complex (ABC) method, using
diaminobenzidine for detection, and hematoxylin for coun-
terstaining. All incubations were conducted at room
temperature.
Extension of the atrial myocardium into the venous tissue
was measured with a calibrated reticule in the lens of an
Olympus (Model E600, Tokyo, Japan) microscope. The
degree of fibrosis and hypertrophy of the atrial myocardium
in the PVs was scored by visual assessment of the micro-
scopic images. The degree of fibrosis was scored as 0 (no
fibrosis), 1 (50% of myocardium fibrotic), and 2 (50% of
myocardium fibrotic). Hypertrophy was scored as 0 (not
present) or 1 (present). We typically looked at cellular and
nuclear shape and size, in comparison with normal atrial
cardiomyocytes, to assess hypertrophy by “visual means.” It
is something we do as a matter of routine on myocardial
biopsy specimens and, as such, is subjective but nonetheless
very reproducible. The whole sections were analyzed and
scored at the same time by two investigators, using an
octopus-microscope, in order to minimize intraobserver and
interobserver variability.
Anatomical analysis. All measurements were made in
freshly obtained unfixed autopsy specimens after removal of
the epicardium. The superior-inferior diameters of the four
PVs, that is, left superior pulmonary vein (LSPV), right
superior pulmonary vein (RSPV), left inferior pulmonary
vein (LIPV), and right inferior pulmonary vein (RIPV),
were determined at the junction with the left atrium. The
lengths of the four PVs were measured from the atriovenous
junction until the total distal end in the lung hilus. The
thicknesses of the PV walls were determined 1 cm proximal
to the atriovenous junction at the anterior and posterior
sites, the parts that were used for histological analysis as
described in the preceding text, of the vein. The thickness of
Abbreviations and Acronyms
AF  atrial fibrillation
LIPV  left inferior pulmonary vein
LSPV  left superior pulmonary vein
PV  pulmonary vein
RIPV  right inferior pulmonary vein
RSPV  right superior pulmonary vein
SMA  smooth muscle actin
Table 1. Patient Characteristics of Pulmonary Vein Histological Analysis
Patient # Gender Age (yrs) AF HTN CAD MI VHD CM OHD Cause of Death
1 F 66 Pneumonia
2 M 46    Subtotal pontine infarct
3 M 59  Hypoxic vasoconstriction
4 M 63 Pulmonary embolus
5 M 74     Acute respiratory distress syndrome
6 M 56 Pulmonary embolus
7 M 81   Congestive heart failure
8 M 72    Massive hepatic hematoma
9 M 82   Acute respiratory distress syndrome
10 M 56   Myocardial infarction
11 F 88     Pulmonary thromboembolism
12 F 88   Congestive heart failure
13 M 65 Hemoperitoneum
14 F 83  Metastatic breast carcinoma
15 M 79    Myocardial infarction
16 M 38 Intraperitoneal hemorrhage
17 F 82   Severe acute bronchopneumonia
18 M 17 Hemorrhagic bronchopneumonia
19 F 30  Pulmonary hypertension
20 F 75   Pulmonary embolus
AF  atrial fibrillation; CAD  coronary artery disease; CM  cardiomyopathy; HTN  hypertension; MI  myocardial infarction; OHD  other heart disease; VHD 
valvular heart disease.
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the left atrial wall was measured between the inferior PVs
(posterior wall) and on the opposite site of the atrium
(anterior wall), 2 cm above the mitral valve.
Statistical analysis. Student t test for unpaired data was
used to evaluate the significance of differences in morpho-
logic appearances of the PVs between the AF and the
non-AF group. Results were expressed as mean  standard
error, and percentages and range. A value of p  0.05 was
considered statistically significant.
Ethics. The institutional review board approved the study,
and the procedures followed during autopsy were in accor-
dance with the institutional guidelines.
RESULTS
Histology. Extension of atrial myocardium into the pul-
monary venous wall (Fig. 1) was found in 89% of the tissue
samples, measuring an average length of 9.3 mm, following
formalin fixation and tissue processing (Table 3). All four
PVs of all 20 patients were analyzed. The average length of
the myocardial sleeves into the LSPVs was 10.9 mm (range,
3.6 to 19.3 mm), into the RSPVs 10.3 mm (1.1 to 25.0
mm), into the LIPVs 8.5 mm (0.6 to 23.5 mm), and into
the RIPVs 7.2 mm (1.88 to 17.0 mm). Myocardial exten-
sion was found in 100% of the PVs from patients with AF
and 85% of the veins from patients without AF (p  0.05).
The average length of myocardial extension into the PVs of
patients with AF was 10.4 ( 4.8) mm, and in patients
without AF 8.7 ( 6.1) mm. Only in the LSPV specimens
did the difference in length of myocardial extension reach
significance, with a mean myocardial extension of 15.1 (
3.8) mm in the AF group and 8.8 ( 3.6) mm in the
non-AF group (p  0.05).
The pulmonary venous myocardial extension appeared to
be discontinuous in 54% of the histology sections (Fig. 2).
There was a significant difference in the frequency of this
finding between the AF group, where it was present in 71%
of PV specimens, and the non-AF group, where it was
present in 46% of the specimens.
The degree of fibrosis and the presence of hypertrophy
were significantly different in the AF and non-AF groups.
Figure 3 shows an example of myocardial fibrosis in the wall of
a PV. The degree of intercellular fibrosis increased progres-
sively in the PV from proximal to distal. Hypertrophic myo-
cardial cells were present in the proximal as well as in the more
peripheral site of the veins. The presence of fibrosis, discon-
tinuous myocardium, and hypertrophy were not particularly
related to one or more PVs, but equally existed in all four veins.
Using immunohistochemical methods, we found no dif-
ference between the staining patterns or staining intensity in
the atrial myocardial components of the PVs in the two
patient groups. The myocytes stained strongly for
troponin-T (Fig. 4). The troponin-T staining identified the
atrial myocytes in the PVs, while staining for SMA only
stained the smooth muscle components of the PVs (Fig. 5).
The staining pattern for the myocardial markers did not
differ from that of myocytes of the atrium proper.
Transition from the atriovenous anatomical junction was
characterized by gradual tapering of either tissue in each
direction from the junction. In the PV wall, the myocardial
sleeve was always external to the smooth muscle layer, in
agreement with a recent study (12).
Recent electrophysiologic studies (6–11) have indicated
that the superior PVs are more frequently involved in the
initiation of AF than the inferior PVs. When comparing all
Table 2. Patient Characteristics of Pulmonary Vein Anatomical Analysis
# Gender Age (yrs) AF HTN CAD MI VHD CM OHD Cause of Death
1–12 Same patients as in Table 1
13 M 77   Mesothelioma
14 F 75   Pneumonia
15 F 63 Ovarian cancer
16 M 53   Intrathoracic hemorrhage
17 M 69  Cerebrovascular accident
Abbreviations as in Table 1.







( SE) p Value
Mean extension of myocardium in all PVs (mm) 9.3 ( 5.7) 10.4 ( 4.8) 8.7 ( 6.1) NS
Mean extension of myocardium in LSPVs (mm) 10.9 ( 4.7) 15.1 ( 3.8) 8.8 ( 3.6) 0.05
Mean extension of myocardium in RSPVs (mm) 10.3 ( 7.7) 10.2 ( 6.4) 10.4 ( 8.7) NS
Mean extension of myocardium in LIPVs (mm) 8.5 ( 5.3) 8.9 ( 1.8) 8.3 ( 6.6) NS
Mean extension of myocardium in RIPVs (mm) 7.2 ( 4.1) 7.2 ( 2.4) 7.2 ( 4.9) NS
Percentage PVs with myocardium extension 89.5 100 84.6 0.05
Percentage PVs with discontinuous myocardium 53.9 70.8 46.2 0.05
Percentage PVs with hypertrophic myocytes 47.9 79.2 32.7 0.05
Degree of fibrosis of myocardium in PVs 1.08 1.58 0.84 0.05
LIPV  left inferior pulmonary vein; LSPV  left superior pulmonary vein; PV  pulmonary vein; RIPV  right inferior pulmonary vein; RSPV  right superior pulmonary
vein.
1110 Hassink et al. JACC Vol. 42, No. 6, 2003
Morphology of Myocardium in Human PVs September 17, 2003:1108–14
superior vein sections with inferior vein sections, the exten-
sion of atrial myocardium in the superior PVs was signifi-
cantly longer than in the inferior veins. The superior veins
had an average extension of 10.6 mm (range, 1.1 to 25.0
mm) versus an extension of 7.7 mm (range, 0.6 to 23.5 mm)
in the inferior PVs (p  0.05).
Anatomy. All four PVs of all 17 patients were anatomically
analyzed (Table 4). As is evident from the morphometric
data in Table 4, a marked variation was present in the
various PV dimensions measured. Correction for heart
weight did not influence the degree of variation. The mean
diameter of the superior PVs was 17.7 mm and for the
inferior PVs 16.5 mm. The diameter of the PVs ranged
from 5 to 30 mm, whereas the length prior to bifurcation of
the PVs ranged from 10 to 54 mm. The wall thickness of
the PVs, presented as the mean of the anterior and the
posterior sites measured, was almost uniformly thin (0.3 to
0.8 mm) in contrast to the wall thickness of the true atrium
(0.6 to 2.6 mm). All these gross anatomical dimensions did
not significantly differ between patients with and without
AF before death. All patients had four PVs; no conjoined
PV orifices were found.
DISCUSSION
Only a limited number of studies have previously reported
the histological appearance of the extended atrial myocar-
dium in human PVs. The present study describes the
histological patterns of the pulmonary venous myocardium,
which may provide insights into the pathophysiologic
mechanisms underlying the arrythmogenicity of these struc-
tures. The key findings of the postmortem histological
analysis include the following:
1) Atrial myocardium extended into 89% of all human PVs.
Extension of atrial myocardium was more frequently
present in the veins of the six patients with a history of
AF compared with the 14 patients without a history of
AF;
2) Significant differences in the histological appearance of
the extended atrial myocardium between these two
patient groups were a higher frequency of discontinuity,
hypertrophy, and a higher degree of fibrosis of pulmo-
nary venous myocardium of patients with compared with
those without a history of AF before death;
Figure 1. Extension of atrial myocardium (red/brown; arrows), stained with Masson’s trichrome, in the wall of a human left superior pulmonary vein from
a patient with atrial fibrillation. (Bottom side of figure represents luminal side of the vein.)
Figure 2. Longitudinal section of a human left superior pulmonary vein from a patient with atrial fibrillation, showing discontinuous atrial myocardium
(arrows) stained with cardiac troponin-T. (Bottom side of figure represents luminal side of the vein.)
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3) Immunohistochemical staining patterns did not differ
between the myocytes in the PV wall and myocytes in
the atrium proper nor between the patients with and
those without a history of AF.
The findings of this study demonstrate that the left atrial
myocardium extends for variable but significant distances
into the PVs. The myocardium found to extend into the
PVs demonstrated the immunohistochemical staining prop-
erties of true atrial myocardium and, thus, was in keeping
with the hypothesis that such a myocardial investiture arises
embryologically from outbudding of the proximal PVs from
the atria. Interestingly, the extension of myocardium ap-
peared to be most pronounced in the superior left PV,
which in some clinical series has been found to be the most
frequent site of focal triggers. The nature of the myocar-
dium was different between the two patient groups, with
hypertrophy and fibrosis being more common in the AF
group. Increased fibrosis in the AF group may be entirely
explained by the patients’ age. Nonetheless, in the light of a
recent canine experimental heart failure study (12), which
showed increased atrial fibrosis in dogs that developed AF,
the presence of fibrosis raises the possibility of a pathophys-
iologic mechanism. It may be of relevance that the incidence
of AF in the general population increases progressively with
age, and fibrosis may provide a possible pathophysiologic
link. Separation of the atrial myocardial bands (discontinu-
ous myocardium) within the PVs was also found more
frequently in the hearts of patients with AF. This finding
may merely represent a normal anatomical variant or reflect
increased stretch and size of the PVs. It is possible that this
anatomical milieu, fibrosis and discontinuous myocardium,
provides an arrhythmogenic substrate. Even mild amounts
of fibrosis within the PVs may result in myocardial clusters,
which are comparatively isolated. This may result in reduced
myocyte coupling and reduced electrotonic inhibition, thus
facilitating automaticity. The degree of intercellular fibrosis
in our study increased progressively in the PV from proximal
to distal such that the most distal myocytes were the most
poorly coupled. This may, in part, explain why exit block is
frequently encountered from single premature beats as well
as from bursts of focal activity from within the PVs. The
recording of discrete spike potentials and, at other sites,
Figure 3. Longitudinal section of a human left superior pulmonary vein from a patient with atrial fibrillation, stained with Masson’s trichrome, showing
loosely coupled atrial cardiomyocytes (red/brown) with high degree (50% of atrial myocardium) of intercellular fibrosis (blue; arrows). (Bottom side of
figure represents luminal side of the vein.)
Figure 4. Longitudinal section of a human left superior pulmonary vein from a patient with atrial fibrillation, with atrial myocardium stained with
monoclonal mouse anti-cardiac troponin-T (brown; arrows). (Bottom side of figure represents luminal side of the vein.)
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fractionated electrograms within a PV may be explained by
isolated distal projections of myocytes and by poorly coupled
myocardium at other sites, respectively. The combination of
poorly coupled cells, fibrosis, and cellular hypertrophy may
lead to slow conduction and, thereby, facilitate local re-entry
within the PVs. Recently, a study in rats suggested the role
of interstitial fibrosis and atrial cell hypertrophy contribut-
ing to the increase in atrial conduction slowing, conduction
block, and inducible AF (13).
In a study published by Saito et al. (14), myocardial
sleeves were recognized in 96 of 99 PVs (97%) examined,
compared with 89% in our study. The prevalence of sleeves
was comparable between patients with and those without
AF in their study, whereas we found a statistically signifi-
cant higher frequency of atrial myocardium in the PVs of
patients with AF. The distances of the myocardial extension
into the PVs in their study group were comparable with our
measurements and in both studies more extensive in the
superior than in the inferior PVs. Saito et al. (14) reported
the same lengths of myocardial sleeves between patients
with and without AF, where we found a significant differ-
ence in the average distance of the myocardial extension in
the LSPVs, being longer in patients with AF. Also, in
contrast to our study, Saito and his colleagues reported no
discontinuity of the extended atrial myocardium. Further-
more, Saito et al. (14) showed the existence of fibrous tissue
in the distal part of the extended atrial myocardium. In our
study this was found significantly more often present in AF
patients compared with non-AF patients. Additionally, we
noticed the presence of hypertrophic cardiomyocytes in the
PVs, especially in those of patients with the atrial arrhyth-
mia. Tagawa et al. (5) reported longer myocardial sleeves in
the superior PVs compared with the inferior PVs as well.
The distances of the sleeves in both inferior PVs reached a
statistically significant difference comparing veins of pa-
tients with and without AF, being longer in the subjects
with the arrhythmia. At the peripheral end, the investigators
found less uniform myocytes and some fibrosis. In our study
we found fibrosis also being present in the proximal part of
the veins. The presence of hypertrophic myocytes and
discontinuous myocardium was not reported in the Tagawa
et al. (5) study.
The use of catheter ablation techniques for the treatment
of focally triggered AF arising from the PVs is growing
rapidly. The present study provides anatomical measure-
ments, which should be instructive in the development of
adequate catheter ablation procedures. There existed a
marked variation in the anatomical dimensions of the PVs.
These gross and variable anatomical measurements have
implications for the development of new catheter ablation
techniques. The gross anatomical variation of the PVs with
respect to diameter and length suggests that circumferential
isolation ablation systems should also be versatile with
respect to inflation diameters and length of the inflated
components, particularly if intended for deployment within
the lumen of the vein itself as opposed to deployment
outside the PV os against the posterior left atrial wall.
The finding that the PV wall is extremely thin (0.5 mm)
in most patients also has significant implications. Inflation
pressures used to deploy balloon-based systems within the
PVs should be limited to reduce the risk of PV rupture as
has occurred in early animal studies, or, alternatively,
Figure 5. Same section as in Figure 4, now stained with monoclonal mouse anti-smooth muscle actin (white arrow; black arrow points to smooth muscle
of vasa vasorum). The smooth muscle layer is always internal from the extended atrial myocardium. (Bottom side of figure represents luminal side of the
vein.)
Table 4. Anatomical Dimensions of Pulmonary Veins
Measurements Mean (mm) SE (mm) Range (mm)
Diameter LSPV 17.9 3.2 11.1–23.4
Diameter RSPV 17.4 6.1 4.8–29.8
Diameter LIPV 16.7 3.7 9.7–21.8
Diameter RIPV 16.3 4.7 5.9–21.4
Length LSPV 40.0 7.6 25.5–53.6
Length RSPV 33.7 7.8 21.9–49.0
Length LIPV 36.2 5.7 30.6–52.5
Length RIPV 29.1 8.4 10.1–47.6
Thickness LSPV wall 0.54 0.16 0.3–0.8
Thickness RSPV wall 0.48 0.14 0.3–0.8
Thickness LIPV wall 0.49 0.15 0.3–0.7
Thickness RIPV wall 0.49 0.15 0.3–0.8
Thickness LA anterior wall 1.6 0.5 1.0–2.4
Thickness LA posterior wall 1.7 0.6 1.1–2.6
LA  left atrial. Other abbreviations as in Table 3.
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intracardiac echocardiography should be used to match the
size of the PV and maximal inflated balloon diameter.
Secondly, the amount of radiofrequency power required to
achieve a transmural lesion within the PVs should be
significantly less than that used in the true atrium, where the
wall is significantly thicker.
Study limitations. Assessment of the degree of fibrosis and
myocyte hypertrophy in this study was done visually, al-
though under the eye of an experienced cardiac pathologist
and, therefore, subjective. The number of patients with AF
in this autopsy study was small, and, as such, this study
represents an initial step in the examination of PV mor-
phology in patients who had AF. Although all the gross
measurements were performed in fresh specimens, the
extension of myocardium into the PVs was determined after
formalin fixation and tissue processing. These procedures
are well known to cause shrinkage of tissues, which is
tissue-type–dependent (15,16). While the specific degree of
shrinkage of the PVs is not established, the range of PV
measurements in this autopsy study is consistent with the
degree of variation we encounter on magnetic resonance
imaging in vivo in patients undergoing PV isolation.
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